Latest Product Development News

QuickFee Limited reports a 9% revenue increase in Q1 FY26 alongside a strategic US Pay Now business sale and a proposed A$28.4 million capital return to shareholders.

Tissue Repair Limited reports steady progress in its Phase 3 clinical trials for chronic wound treatment and advances regulatory filings for its TR Pro+® product, while gearing up for a major commercial rollout in early 2026.

Resonance Health reports positive cash flow and significant progress in its clinical trials and Software-as-a-Medical Device business, setting the stage for growth in new international markets.

Atomo Diagnostics reported strong commercial momentum in Q1 FY26, highlighted by a key FDA submission for its FebriDx test and a successful capital raise of $1.3 million. The company also showcased promising clinical data for its Active Syphilis test and expanded its HIV Self-Test distribution channels.

Zimi Limited reported a remarkable 367% increase in quarterly revenue alongside a successful $1.85 million capital raise and completion of its manufacturing relocation, setting the stage for accelerated growth in the smart home IoT sector.

Sarytogan Graphite Limited has secured major engineering contracts for its Definitive Feasibility Study, setting the stage for construction in 2027. The project’s strategic importance under the EU Critical Raw Materials Act highlights its role in the battery minerals supply chain.

Swift Networks has locked in key contracts with Australia's largest Aged Care provider and Chevron, while progressing its Swift TV rollout on track for Q3 FY26. The company also completed a $2.2 million capital raise, positioning itself for growth in new markets.

Hydrocarbon Dynamics Limited has reactivated its North Sea trial and completed a fully underwritten rights issue raising $718,741, while advancing multiple international projects and exploring new energy ventures.

Anteris Technologies Global Corp. has had its trading suspension lifted following a key announcement about its capital raising plans, signaling renewed market activity.

Optiscan Imaging Ltd secured $17.75 million in a fully underwritten equity raise, fueling clinical studies and regulatory preparations for its innovative medical imaging devices. The company also reported progress in international trials and strengthened its cash position to nearly $20 million.

X2M Connect Limited kicks off FY26 with a 25% revenue surge and a significant reduction in net debt, backed by major new contracts across Asia and the Middle East.

xReality Group (XRG) has reported robust growth driven by its flagship Operator XR training system, securing a landmark $5.7 million contract with the Texas Department of Public Safety and unveiling ambitious plans for new product launches and global expansion.